Clinical Trial Update: Treating Hepatitis C in CRF Using Sofosbuvir and Daclatasvir [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial completed evaluating sofosbuvir and daclatasvir for treating hepatitis C in patients with chronic renal failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hepatitis C

Drugs mentioned

• sofosbuvir and daclatasvir (sofosbuvir; daclatasvir)

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Hepatitis C, Chronic, Chronic Renal Failure | Phase 4 | Status: COMPLETED